Literature DB >> 9223068

Glucocorticoids modulate the cellular disposition of lipocortin 1 in the rat brain in vivo and in vitro.

J G Philip1, R J Flower, J C Buckingham.   

Abstract

The role of glucocorticoids in the regulation of lipocortin 1 (LC1) mRNA/protein expression in the brain is uncertain. This study has examined the influence of dexamethasone on the disposition of LC1 protein in various central and peripheral tissues in the rat. LC1 was readily detectable in all tissues studied by Western blot analysis. Exposure to dexamethasone in vitro (0.1 microM, 3 h) or in vivo (20 micrograms/100 g i.p., 24 h before autopsy) had no discernible effects on intracellular LC1 levels but increased the amount of LC1 attached to the outer surface of cells (pericellular LC1) in cortex, hippocampus, hypothalamus, pituitary gland and peritoneal macrophages (in vitro only). The results suggest that in central tissues, as in the periphery, glucocorticoids promote the translocation of LC1 from intracellular to pericellular sites.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223068     DOI: 10.1097/00001756-199705260-00016

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  13 in total

1.  Evidence from immunoneutralization and antisense studies that the inhibitory actions of glucocorticoids on growth hormone release in vitro require annexin 1 (lipocortin 1).

Authors:  A D Taylor; H C Christian; J F Morris; R J Flower; J C Buckingham
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Proteomic profiling of rat lung epithelial cells induced by acrolein.

Authors:  Poonam Sarkar; Barbara E Hayes
Journal:  Life Sci       Date:  2009-05-30       Impact factor: 5.037

3.  Multiple signaling pathways involved in stimulation of osteoblast differentiation by N-methyl-D-aspartate receptors activation in vitro.

Authors:  Jie-li Li; Lin Zhao; Bin Cui; Lian-fu Deng; Guang Ning; Jian-min Liu
Journal:  Acta Pharmacol Sin       Date:  2011-06-20       Impact factor: 6.150

Review 4.  Nongenomic actions of adrenal steroids in the central nervous system.

Authors:  N K Evanson; J P Herman; R R Sakai; E G Krause
Journal:  J Neuroendocrinol       Date:  2010-03-27       Impact factor: 3.627

Review 5.  Annexin 1, glucocorticoids, and the neuroendocrine-immune interface.

Authors:  Julia C Buckingham; Christopher D John; Egle Solito; Tanya Tierney; Roderick J Flower; Helen Christian; John Morris
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

6.  Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1.

Authors:  L Minghetti; A Nicolini; E Polazzi; A Greco; M Perretti; L Parente; G Levi
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

7.  Gene deletion reveals roles for annexin A1 in the regulation of lipolysis and IL-6 release in epididymal adipose tissue.

Authors:  James P Warne; Christopher D John; Helen C Christian; John F Morris; Roderick J Flower; David Sugden; Egle Solito; Glenda E Gillies; Julia C Buckingham
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-07-11       Impact factor: 4.310

8.  Lack of annexin 1 results in an increase in corticotroph number in male but not female mice.

Authors:  J F Morris; S Omer; E Davies; E Wang; C John; T Afzal; S Wain; J C Buckingham; R J Flower; H C Christian
Journal:  J Neuroendocrinol       Date:  2006-11       Impact factor: 3.627

9.  Opposing influences of glucocorticoids and interleukin-1beta on the secretion of growth hormone and ACTH in the rat in vivo: role of hypothalamic annexin 1.

Authors:  J G Philip; C D John; P O Cover; J F Morris; H C Christian; R J Flower; J C Buckingham
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

10.  Increased susceptibility of annexin-A1 null mice to nociceptive pain is indicative of a spinal antinociceptive action of annexin-A1.

Authors:  S S Ayoub; S Yazid; R J Flower
Journal:  Br J Pharmacol       Date:  2008-05-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.